Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Lipoprotein Stories

2014-04-10 11:17:19

Should dental health now be considered a marker of coronary heart disease? Periodontal disorders such as tooth loss and gingivitis have been identified as a potential risk marker for cardiovascular disease in a large study reported today. More than 15,000 patients with chronic coronary heart disease provided information on their dental health, with results showing that indicators of periodontal disease (fewer remaining teeth, gum bleeding) were common in this patient group and associated...

2014-03-31 12:07:41

In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. The American...

2014-01-22 23:31:09

Kalen Biomedical, LLC (http://www.kalenbiomed.com) is pleased to announce a distribution agreement with MRTeck Co. in South Korea. Montgomery Village, MD (PRWEB) January 22, 2014 Kalen Biomedical, LLC has signed a distribution agreement with MRTeck Co. to offer premium lipoproteins to researchers in Korea. Kathy K. Foxx, President of Kalen Biomedical said, “We have a long relationship with MRTeck and are pleased to formalize it. Their reputation for serving the medical research...

2013-12-04 12:26:49

MAPLE GROVE, Minn., Dec. 4, 2013 /PRNewswire/ -- Dietary supplements are dominating the shelves of pharmacy retailers, with brands vying for the attention of health-conscious consumers. In fact, industry experts report that approximately 50% of American adults take dietary supplements. Despite the Dietary Supplement Health and Education Act (DSHEA) governing manufacturing, packaging and holding standards for the dietary supplement industry, it is difficult for consumers to be sure...

2013-11-13 13:56:31

Researchers at the University of Copenhagen, Rigshospitalet and Herlev Hospital have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular heart disease. The new findings have just been published in the Journal of the American College of Cardiology. Aortic valve stenosis (AS) – in which the opening of the aortic valve is narrowed – affects 2-7 percent of the Danish population aged...

2013-10-15 08:30:19

IRVINE, Calif., Oct. 15, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Erik SG Stroes, MD, Chair and Professor at the Department of Vascular Medicine at the Academic Medical Center (AMC), Amsterdam has joined the Company as a member of the Clinical Advisory Board. "We are pleased to announce that Dr. Stroes...

2013-09-04 08:14:56

In a randomized trial that included about 2,000 patients with or at high risk of cardiovascular disease (CVD), use of a fixed-dose combination medication for blood pressure, cholesterol, and platelet control compared to usual care resulted in significantly improved medication adherence after 15 months and small improvements in systolic blood pressure and low-density lipoprotein cholesterol, according to a study in the September 4 issue of JAMA. "The long-term use of cardiovascular disease...

2013-06-23 12:20:04

Data Presentation Demonstrates Value of Lipoprotein Measurement in Identifying Insulin-Resistant Patients at Increased Risk of Developing Type 2 Diabetes RALEIGH, N.C., June 23, 2013 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced the presentation of data at the 73(rd)...

2013-04-17 16:25:49

Dr. John Kastelein Appointed Co-Principal Investigator IRVINE, Calif., April 15, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that John J.P. Kastelein, MD, PhD, Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center and Strategic Chair of Genetics in Cardiovascular Disease at...

2013-03-22 23:04:43

GUARDaHEART, a non-profit foundation committed to raising awareness about Heart Disease prevention, held a heart health event on March 20, 2013 at the State Capitol of California. Sacramento, CA (PRWEB) March 22, 2013 GUARDaHEART, a non-profit foundation committed to raising awareness about Heart Disease prevention, held a heart health event on March 20, 2013 at the State Capitol hosted by Assemblyman Don Wagner, R-Irvine and Assemblywoman Diane Harkey, R-Dana Point to celebrate the State...